Introduction Few validated prognostic factors are available for survival in patients with lung
cancer.[18 F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to …

Lung cancer (LC) still represents one of the most common tumours in both women and men.
PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used …

Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

We sought to quantify contribution of radiomics and SUVmax at PET/CT to predict clinical
outcome in lung cancer patients treated with stereotactic body radiotherapy (SBRT). 150 …

Purpose We evaluated the prognostic impact of volume-based assessment by 18 F-FDG
PET/CT in patients with stage III non-small-cell lung cancer (NSCLC). Methods We reviewed …

A greater understanding of non–small-cell lung cancer at a molecular level has led to the
identification of an increasing number of driver mutations. Extensive research of the KRAS …

Purpose We investigated fluorine-18 fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT)-assessed metabolic tumor volume (MTV) …

Lung cancer is one of the most frequently occurring neoplasms and usually has a poor
prognosis because most of the patients present with advanced or metastatic disease at the …

Simple Summary PET enables quantitative assessment of tumour biology in vivo.
Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect tumour metabolic activity …

The integral role of positron-emission tomography (PET) using the glucose analog tracer
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …